EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitLeitlinieOpen Access · CC BY 4.0

A Targeted Review of Worldwide Indirect Treatment Comparison Guidelines and Best Practices

Shiro Tanaka, Ataru Igarashi, Raf De Moor, Nan Li, Mariko Hirozane, Li Wen Hong, David Bin-Chia Wu, Dae Young Yu, Mahmoud Hashim, Brian Hutton, Krista Tantakoun, Christopher Olsen und 3 weitere

Value in Health · 2024-09 · 27 (9) · 1179-1190

DOI: 10.1016/j.jval.2024.05.015 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Value in Health, 2024-09. Verfasst von Shiro Tanaka und 14 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of medicine, Kyoto University, Kyoto, Japan. Hauptthemen laut MEDLINE: Practice Guidelines as Topic. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Janssen Pharmaceutica, Janssen Pharmaceutical KK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: Controls and governance over the methodology and reporting of indirect treatment comparisons (ITCs) have been introduced to minimize bias and ensure scientific credibility and transparency in healthcare decision making. The objective of this study was to highlight ITC techniques that are key to conducting objective and analytically sound analyses and to ascertain circumstantial suitability of ITCs as a source of comparative evidence for healthcare interventions. METHODS: Ovid MEDLINE was searched from January 2010 through August 2023 to identify publicly available ITC-related documents (ie, guidelines and best practices) in the English language. This was supplemented with hand searches of websites of various international organizations, regulatory agencies, and reimbursement agencies of Europe, North America, and Asia-Pacific. The jurisdiction-specific ITC methodology and reporting recommendations were reviewed. RESULTS: Sixty-eight guidelines from 10 authorities worldwide were included for synthesis. Many of the included guidelines were updated within the last 5 years and commonly cited the absence of direct comparative studies as primary justification for using ITCs. Most jurisdictions favored population-adjusted or anchored ITC techniques opposed to naive comparisons. Recommendations on the reporting and presentation of these ITCs varied across authorities; however, there was some overlap among the key elements. CONCLUSIONS: Given the challenges of conducting head-to-head randomized controlled trials, comparative data from ITCs offer valuable insights into clinical-effectiveness. As such, multiple ITC guidelines have emerged worldwide. According to the most recent versions of the guidelines, the suitability and subsequent acceptability of the ITC technique used depends on the data sources, available evidence, and magnitude of benefit/uncertainty.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Practice Guidelines as TopicHumansComparative Effectiveness ResearchDecision MakingCost-Benefit Analysis

Stichwörter der Autor:innen

guidelineshealth technology assessmentindirect treatment comparisonpolicy

Autor:innen und Institutionen

  • Faculty of medicine, Kyoto University, Kyoto, Japan.
  • Unit of Public Health and Preventive Medicine, Yokohama City University School of Medicine, Yokohama, Japan.
  • Value, Evidence and Access Department, IMAT, Janssen Pharmaceutical K.K., Tokyo, Japan.
  • Policy Department, IMAT, Janssen Pharmaceutical K.K., Tokyo, Japan.
  • Asia Pacific Regional Market Access, Janssen Pharmaceutical Companies of Johnson and Johnson, Singapore.
  • Asia Pacific Regional Market Access, Janssen Pharmaceutical Companies of Johnson and Johnson, Singapore; Saw Swee Hock School of Public Health, National University of Singapore, Singapore.

Förderung

  • Janssen Pharmaceutica
  • Janssen Pharmaceutical KK

Zitieren

APA

Tanaka, S., Igarashi, A., De Moor, R., Li, N., Hirozane, M., Hong, L. W., Wu, D. B., Yu, D. Y., Hashim, M., Hutton, B., Tantakoun, K., Olsen, C., Mirzayeh Fashami, F., Samjoo, I. A., & Cameron, C. (2024). A Targeted Review of Worldwide Indirect Treatment Comparison Guidelines and Best Practices. Value in Health, 27(9), 1179-1190. https://doi.org/10.1016/j.jval.2024.05.015

Vancouver

Tanaka S, Igarashi A, De Moor R, Li N, Hirozane M, Hong LW, et al. A Targeted Review of Worldwide Indirect Treatment Comparison Guidelines and Best Practices. Value in Health. 2024;27(9):1179-1190. doi:10.1016/j.jval.2024.05.015

BibTeX
@article{Tanaka2024,
  author = {Tanaka, Shiro and Igarashi, Ataru and De Moor, Raf and Li, Nan and Hirozane, Mariko and Hong, Li Wen and Wu, David Bin-Chia and Yu, Dae Young and Hashim, Mahmoud and Hutton, Brian and Tantakoun, Krista and Olsen, Christopher and Mirzayeh Fashami, Fatemeh and Samjoo, Imtiaz A and Cameron, Chris},
  title = {A Targeted Review of Worldwide Indirect Treatment Comparison Guidelines and Best Practices},
  journal = {Value in Health},
  year = {2024},
  volume = {27},
  number = {9},
  pages = {1179--1190},
  doi = {10.1016/j.jval.2024.05.015}
}
Kostenlos starten →